Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of Tolvaptan in patients with autosomal dominant polycystic kidney disease. — Giuseppe Remuzzi | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Shared by
Giuseppe Remuzzi
Faculty Opinions recommendation of Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Dataset
en
Authors
Giuseppe Remuzzi
AS
Arrigo Schieppati
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
Giuseppe Remuzzi
,
Arrigo Schieppati
Dataset
Faculty Opinions recommendation of Volume progression in polycystic kidney disease.
Giuseppe Remuzzi
Article
2017
[Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].
Norberto Perico
,
Monica Cortinovis
,
Giuseppe Remuzzi
Article
2006
Computed Tomography Evaluation of Autosomal Dominant Polycystic Kidney Disease Progression
Luca Antiga
,
Marina Piccinelli
,
Giorgio Fasolini
,
Bogdan Ene‐Iordache
,
Patrizia Ondei
,
Simona Bruno
,
Giuseppe Remuzzi
,
Andrea Remuzzi
Article
2023
Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial
Matias Trillini
,
Anna Caroli
,
Norberto Perico
,
Andrea Remuzzi
,
Paolo Brambilla
,
Giulia Villa
,
Annalisa Perna
,
Tobia Peracchi
,
Nadia Rubis
,
Davide Martinetti
,
Rosa Caruso
,
Valentina Fanny Leone
,
Daniela Cugini
,
Fabiola Carrara
,
Giuseppe Remuzzi
,
Piero Ruggenenti
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.